611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Health Tip: Recognizing Heat ExhaustionInsect Stings Are Just a Buzzkill for Most FolksDisinfectants Can't Stop This Dangerous Hospital GermHealth Tip: Working in Extreme HeatHealth Tip: Diarrhea in KidsHow to Protect Your DNA for Big Health BenefitsNewer Lung Cancer Screening Saves More LivesHigh Blood Pressure, 'Bad' Cholesterol Risky for Young, TooSummer Can Be Hard on Your HearingMany Pneumonia Patients Get Too Many AntibioticsAdopt a Diet That's Good for Your GutAHA News: 5 Threats to Heart Health You May Not Be Aware OfTongue, Lip Snip Surgeries May Be Overused in U.S. NewbornsHealth Tip: Foods With LactoseHealth Tip: Living With Celiac DiseaseMore Evidence Fried Food Ups Heart Disease, Stroke RiskBrain Injury Often a Devastating Side Effect of Domestic ViolenceNew Migraine Drug Might Help When Other Meds Don'tXpovio With Dexamethasone Approved for Refractory Multiple MyelomaPoor Social Life Could Spell Trouble for Older Women's BonesIs Your Mattress Releasing Toxins While You Sleep?Zika's Damage Continues in Children Infected Before BirthCDC Warns of Start to 'Season' for Mysterious Paralyzing Illness in KidsShould You Try Allergen Immunotherapy?Dangerous UTIs Can Follow Hospital Patients HomeMore Evidence Supplements Won't Help the Heart'Semi-Slug' Is Spreading a Lethal Parasite in HawaiiAHA News: 'Surprising' Lack of Progress on Heart Disease in Younger AdultsSmall Vessel Disease Leaves Patients Vulnerable to Leg AmputationHealth Tip: Eating Out If You Have a Food AllergyHow to Create a Diet That Lowers Your CholesterolHow Protect Against Short- and Long-Term Sun DamageSurgeons Give 13 Paralyzed Adults Hand, Arm MovementIt's Mosquito Season: Here's How to Protect YourselfConcussion Recovery Isn't the Same for Every Football PlayerOften Feel Bloated? One Ingredient May Be to BlameFor Many, Pot Is Now an Alternative to Opioids or Sleep MedsSurgery Helps Babies Missing a Heart Chamber Survive, But Problems LingerAnti-Vaccine Movement a 'Man-Made' Health Crisis, Scientists WarnCan Stem Cells Be the Cure for Baldness?Cancer Risk Rises After Iodine Rx for Overactive Thyroid: StudyGut Bacteria Supplements Might Boost Obese People's HealthEye Injuries From Fireworks in U.S. Have Nearly DoubledHealth Tip: Swallowing ProblemsMedtronic Recalls Some Insulin Pumps as FDA Warns They Could Be HackedAir Pollution Bad News for Your Blood PressureFDA Approves First Drug for Sinusitis With Nasal PolypsInfections, Especially UTIs, May Be Triggers for StrokesCould Heavier Folks Be at Lower Risk for ALS?A New Way to Spot Consciousness Earlier in Comatose Patients?
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Window for Safe Use of Clot-Buster Widens for Stroke Patients

HealthDay News
by By Amy NortonHealthDay Reporter
Updated: May 8th 2019

new article illustration

WEDNESDAY, May 8, 2019 (HealthDay News) -- For years, many people suffering a stroke have not been able to get a critical drug due to time limits on its use. Now, a new study suggests that treatment time window can be doubled.

Experts said the findings could open up the treatment option for many more stroke victims.

The drug is called tissue plasminogen activator, or tPA. It can dissolve the blood clot causing a person's stroke, and protect brain tissue from any further damage. However, tPA has to be given within a certain time frame to work.

Long-time guidelines stated that the drug should be infused within three hours of the first stroke symptoms -- or, for certain patients, within 4.5 hours.

That has limited its use. One problem is that people often do not recognize the signs of a stroke and delay going to the hospital, explained Dr. Randolph Marshall, a professor of neurology at Columbia University, in New York City.

He wrote an editorial published with the study.

Another issue is that some people wake up in the midst of a stroke, and it's unclear when the symptoms began.

So, at least as of 2013, only about 6% of patients hospitalized for an ischemic stroke received tPA, according to Marshall.

Ischemic strokes are caused by a clot that blocks blood flow to the brain, and they account for the large majority of all strokes.

In the new trial, researchers looked at whether they could expand the tPA time frame to nine hours in certain ischemic stroke patients. Specifically, that meant cases where brain imaging showed the drug could still be beneficial.

The study took advantage of a newer technology called "perfusion" imaging.

"It allows us to see the area of brain damage, and whether there is still tissue that's salvageable," Marshall explained. It's done using either a CT or MRI scanner.

When patients did have savable brain tissue, the trial found, giving tPA as late as nine hours after the first symptoms still brought benefits. Three months later, over 35% of those patients had no or minimal disability from their stroke.

That compared with 29.5% of patients who were given infusions of a placebo (along with other standard stroke care).

The benefit did come at a price. About 6% of tPA patients had bleeding in the brain -- a known side effect of the drug. But that figure is similar to what's seen when tPA is given earlier, too, Marshall pointed out.

Dr. Geoffrey Donnan, a neurologist at the University of Melbourne, in Australia, led the study.

He said the findings suggest that perfusion imaging should be done whenever a stroke patient either woke up with symptoms, or can be treated within 4.5 to nine hours of their first symptoms.

Perfusion imaging is not universally available, though. Right now, it's mainly used at larger hospitals with comprehensive stroke care, according to Marshall.

The findings are based on 225 stroke patients at hospitals in Australia, Taiwan and New Zealand. All underwent perfusion imaging and were shown to have savable brain tissue. Donnan's team randomly assigned them to have an infusion of either tPA or a placebo fluid.

Many of the patients had woken up with stroke symptoms. Others were known to have suffered their first symptoms within 4.5 to nine hours of being randomly assigned to their treatment.

Still, tPA is not the only stroke treatment option. Doctors can also physically remove the blood clot, using a scope that's threaded into the blocked brain artery. In fact, that procedure -- called a thrombectomy -- can be done as late as 24 hours after the first symptoms in some patients.

It's not known whether giving tPA in the later window would be preferable to a thrombectomy, according to Marshall.

"I think that will be the next big trial -- to compare this with thrombectomy," he said.

For now, Marshall and Donnan both stressed that people should learn the signs and symptoms of stroke, and never delay medical care.

The most common symptoms include sudden weakness or numbness in the face or arm (usually on one side of the body), slurred speech, and sudden difficulty walking or seeing, according to the American Stroke Association.

More information

The American Stroke Association has more on stroke treatment.